PIRS - Pieris Pharmaceuticals Q4 2022 Earnings Preview
2023-03-28 14:23:38 ET
- Pieris Pharmaceuticals ( NASDAQ: PIRS ) is scheduled to announce Q4 earnings results on Wednesday, March 29th, before market open.
- The consensus EPS Estimate is -$0.13 and the consensus Revenue Estimate is $6.51M
For further details see:
Pieris Pharmaceuticals Q4 2022 Earnings Preview